Literature DB >> 25080479

Retraction of the research article: "CD4⁺ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy".

Alberto K De la Herrán-Arita1, Birgitte Rahbek Kornum, Josh Mahlios, Wei Jiang, Ling Lin, Tieying Hou, Claudia Macaubas, Mali Einen, Giuseppe Plazzi, Catherine Crowe, Evan W Newell, Mark M Davis, Elizabeth D Mellins, Emmanuel Mignot2.   

Abstract

Entities:  

Year:  2014        PMID： 25080479     DOI： 10.1126/scitranslmed.3009995

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


× No keyword cloud information.
  8 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

2.  Neuroimmunology: Disease mechanisms in narcolepsy remain elusive.

Authors:  Ilkka Julkunen; Markku Partinen
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

Review 3.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

4.  CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1.

Authors:  Melanie Ramberger; Birgit Högl; Ambra Stefani; Thomas Mitterling; Markus Reindl; Andreas Lutterotti
Journal:  Sleep       Date:  2017-03-01       Impact factor: 5.849

Review 5.  Hypocretin as a Hub for Arousal and Motivation.

Authors:  Susan M Tyree; Jeremy C Borniger; Luis de Lecea
Journal:  Front Neurol       Date:  2018-06-06       Impact factor: 4.003

6.  Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.

Authors:  Guo Luo; Aditya Ambati; Ling Lin; Mélodie Bonvalet; Markku Partinen; Xuhuai Ji; Holden Terry Maecker; Emmanuel Jean-Marie Mignot
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-12       Impact factor: 11.205

7.  A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis.

Authors:  Alexander Lind; Ilaria Marzinotto; Cristina Brigatti; Anita Ramelius; Lorenzo Piemonti; Vito Lampasona
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

8.  Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines.

Authors:  Aditya Ambati; Guo Luo; Elora Pradhan; Jacob Louis; Ling Lin; Ryan D Leib; Hanna Maria Ollila; Thomas Poiret; Christopher Adams; Emmanuel Mignot
Journal:  Vaccines (Basel)       Date:  2020-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.